Official UK procurement notice
Licence variation: spironolactone for acne in women
Authority: NHS England (Central government)·Consortium: 3 public authorities
What is being bought
Published requirement descriptionNHS England required a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
CPV: Health services · Pharmacy services
The lotProcurement structure
single lot · value publishedLot #1CancelledPublished value£171,500
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published award criteria (3)
- Quality: 60
- Social Value: 10
- Price: 30
- Economic & financial standing
Selection criteria as stated in the procurement documents.
Minimum: Selection criteria as stated in the procurement documents. - Technical & professional ability
Selection criteria as stated in the procurement documents.
Minimum: Selection criteria as stated in the procurement documents.
- Price carries 30 of 100 points: a 10% discount moves about 3 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Cancelled
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 8 May 2024, 15:33 BST
- Last source update
- 17 Jan 2025, 15:30 GMT
- Award evaluation window
- 5 Sept 2024 – …
- Authority reference
C301713- FTS notice number
2025/S 000-001753- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-045808Find a Tender
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 7 Oct 2024, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 5 Sept 2024, 16:00 BST
Timeline
15 Jul 2024 → 17 Jan 2025 · 5 dates- Next notice expected15 Jul 2024, 00:00 BST
- Bids opened5 Sept 2024, 16:00 BST
- Submission deadline7 Oct 2024, 12:00 BST
- Contract starts2 Dec 2024
- Notice published17 Jan 2025, 15:30 GMT
Notice history
9 events · 6 releases on Find a Tender · since 19 Jun 2024- Status changed to active19 Jun 2024, 16:45 BST
- Procurement method changed19 Jun 2024, 16:45 BST
- Deadline published: 31 Jul 2024, 12:00 BST19 Jun 2024, 16:45 BST
- Buyer details updated2 Jul 2024, 17:16 BST
- Published value published: £171,5005 Sept 2024, 19:21 BST
- Deadline moved to 7 Oct 2024, 12:00 BST5 Sept 2024, 19:21 BST+68 days · was 31 Jul 2024, 12:00 BST
- Buyer details updated5 Sept 2024, 19:21 BST
- Status changed to unsuccessful17 Jan 2025, 15:30 GMT
- Buyer details updated17 Jan 2025, 15:30 GMT
Published amendments (4 · 0 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | Contract periodII.2.7.4 | 30 Jun 2026 | 30 Sept 2026 | +92 d |
| — | TextII.1.1.1 | Licensing Spironolatone for Acne in Women | Licensing Spironolactone for Acne in Women | |
| — | Contract periodII.2.7.4 | 30 Jun 2026 | 30 Sept 2026 | +92 d |
| — | TextII.1.1.1 | Licensing Spironolatone for Acne in Women | Licensing Spironolactone for Acne in Women |
4 amendments published without a description.
Routine re-releases (6)
- 2024-07: 1 release · 2 Jul 2024
- 2024-06: 1 release · 19 Jun 2024
- 2024-05: 1 release · 8 May 2024
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 further award records carry no date or value.
Contracting authority & participating public bodies
2 public bodies on the noticeDispute resolution & review bodies
- The High CourtReview bodyReview contact point
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.